The 3rd Saving Lives Sustainably: Sustainable Production in the Health Sector Global Forum 2020 is taking place on 18-19 November 2020, under the theme, “Recovering Better after COVID-19 with Sustainable Production and Procurement of Health Commodities.”
The Saudi Food and Drug Authority signed with its Indonesian counterpart today (Thursday) 23 Dhu al-Hijjah 1441 AH corresponding to August 13, 2020 CE, a memorandum of understanding aimed at strengthening control over the quality and safety of medicinal products, including vaccines, biological products, cosmetics, nutritional supplements and processed foods
An electronic system that enables users to issue a bill to get SFDA service
SFDA established Product Classification System for companies to classify their products and get to know the eligibility of products and whether it is subject to registration. The classification exclusively based on the SFDA criteria and products classification guidance. It is an optional service for companies and does not replace registration for other SFDA electronic systems
The leading regional regularity authority for food, drugs and medical devices with proffessional and excellent services that contributes to the protection and advancement of the health in Saudi Arabia
The British Ambassador, Mr. Simon Collis visited SFDA headquarters in Riyadh, in order to meet with his Excellency the Chief Executive Officer, Dr. Hisham bin Saad Al Jadhey.
The parties have discussed important means of cooperation between the two countries regarding the scoop of food.
Saudi Arabia represented GCC states in the International Council for Harmonisation (ICH), held in Singapore.
The meeting is considered as the largest meeting in the world in the field of creation, development and review of pharmaceutical legislation.
SFDA participated in the (ICH) for the first time with its new membership after being elected from the council in 2019 mid-year.
The Saudi Food and Drug Authority (SFDA), resembled by the National Pharmacovigilance Centre (NPC), is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events (heart attack, stroke, resuscitated cardiac arrest, or death) than patients using a placebo (sugar pill). Sibutramine is marketed as Reductil, a prescription drug, in Saudi Arabia.
.png)
